Drs Kaberi Dasgupta, Louise Pilote and Suzanne Morin awarded as part of nineprovince consortium $11.3 million dollars over three years for CANTRAIN – a unique training initiative to improve clinical trials
Drs Kaberi Dasgupta, Louise Pilote and Suzanne Morin were awarded as part of a nineprovince consortium $11.3 million dollars over three years for CANTRAIN – a unique training initiative to improve clinical trials. The aim is to build Canadian expertise in the conduct of clinical trials by adopting an equitable, diversified, and inclusive approach to training the professionals who conduct clinical trials.
Recently the Accelerating Clinical Trials (ACT) Consortium was awarded $39 million over three years by the federal government to accelerate the conduct of Canadian-led clinical trials so that information generated can quickly be applied to improve health outcomes of all Canadians. Congratulations to Dr Louise Pilote who co-chairs the RI-MUC participation on the ACT operating committee and Dr Emily McDonald who is the early career clinical trialist on the operation committee. ACT brings together hundreds of researchers from 28 networks, 11 trial units from Nova Scotia to British Columbia and Nunavut, as well as patient-partners, 20 hospitals, and industry partners.